NeuroOne Medical Technologies Corp reports results for the quarter ended June 30 - Earnings Summary

Neuroone Medical Technologies

13/08/2026 15:12

NeuroOne Medical Technologies Corp NMTC.OQ reported a quarterly adjusted loss of 23 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -18 cents.  The mean expectation of three analysts for the quarter was for a loss of 22 cents per share. Wall Street expected results to range from -26 cents to -17 cents per share.
Revenue rose 16.3% to $1.97 million from a year ago; analysts expected $2.55 million. 
NeuroOne Medical Technologies Corp's reported EPS for the quarter was a loss of 23 cents​.
The company reported a quarterly loss of $2.01 million.
NeuroOne Medical Technologies Corp shares had fallen by 50.0% this quarter and lost 66.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for NeuroOne Medical Technologies Corp is $8.80, about 82.7% above its last closing price of $1.52
This summary was machine generated from LSEG data August 13 at 02:12 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.22
-0.23
Missed
Mar. 31 2026 
-0.23
-0.25
Missed
Dec. 31 2025 
-0.24
-0.18
Beat
Sep. 30 2025 
-0.24
-0.24
Met